Abstract: Antileishmanial activity of several classes of natural compounds was evaluated by using an in vitro parasitic assay model. This has led to the discovery of new antileishmanial agents with potential to be useful in the treatment of visceral and cutaneous leishmaniasis.
side effects such as hypoglycemia, diabetes, nephrotoxicity, and pain at the site of infection. The antibiotic amphotericin B is another drug used for the treatment of visceral leishmaniasis. It shows better results in cases resistant to antimonials and diamidines, but it leads to nephrotoxicity and cardiotoxicity. The emergence of drug resistance in Leishmania parasites is a major obstacle to their control. About 5-70 % of the patients in some endemic areas sometimes do not respond to standard antiparasitic drugs. Therefore, the search for novel, effective, and safe drugs for the treatment of the diseases has been a priority for health researchers [1, 4] .
Medicinal plants have been used for centuries for the treatment of various ailments. Plants are an important source for drug candidates, particularly against parasites because of their long association with parasites. Over 100 plants have been reported to be active against various forms of leishmanial parasites [5] .
During the current study, we focused our efforts on discovering effective antileishmanial agents to control visceral and cutaneous leishmaniasis. Our main strategy was to screen a large number of natural products that researchers have obtained from medicinal plants and other living sources. For this purpose, a high-throughput in vitro assay was employed. L. major promastigotes were cultured in the logarithmic phase, and the final concentration of parasites was adjusted to 2 × 106 parasites/mL. The test compounds were dissolved in dimethyl sulfoxide (DMSO), and their volume was made up with RPMI-1640. Test compounds were added in serial dilution. The parasite suspension was added into each well of the 96-well plates, and incubated at 21-22°C for 72 h, in the presence and absence of amphotericin B (pos. control). The experiments were carried out in duplicate, and the number of surviving parasites were counted. The 50 % inhibitory concentration (IC 50 ) was determined. The details of the assay are reported in references herein. As a result, the following classes were identified as antileishmanial agents.
PHYSALINS
Several physalins, 1-4 and 7-10, and a withanolide 11 were isolated from Physalis minima Linn. (Solanaceae) [6] [7] [8] . Compounds 5, 6, and 9 were obtained by biotransformation of 3 by Rhizopus stolonifer and Cunninghamella elegans (Fig. 1 ). Physalins are steroidal lactone constituents of Physalis and other closely related genera. All these compounds showed potent leishmanicidal activity against the promastigotes of L. major (Table 1) . Structure analysis of physalins showed that the presence of hydroxyl groups at C-5, C-6, and C-11 appears to play a major role in the activity against leishmaniasis. Compound 1 showed IC 50 = 0.92 µg/mL as compared to the standard drug amphotericin B, IC 50 = 0.12 µg/mL, while the absence of OH groups significantly decreased the activity as shown by the IC 50 value of compound 2 (IC 50 = 5.00 µg/mL).
Compound 3 also showed substantial antileishmanial activity (IC 50 = 3.39 µg/mL). The biotransformed products 5-6 and 9 showed a decrease in activity probably due to the absence of the C-6 hydroxyl group from compound 3. Withanolide 11 did not show any activity (IC 50 = 38.9 µg/mL).
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STEROIDAL ALKALOIDS
Several steroidal alkaloids 12-28 were isolated from Sarcococca hookeriana (Baill.) Hook. f. (Buxaceae) (Fig. 2) . Steroidal alkaloids are commonly called "steroidal alkamines" and bear a cyclopentanophenanthrene skeleton. These compounds and their derivatives were found to have potentto-mild antileishmanial activity [9] .
ATTA-UR-RAHMAN et al. The study indicated that the functionalities present on the steroidal skeleton play an important role in the leishmanicidal activity (Table 2 ). Compound 13 with senecioylamino, α-hydroxy, and β-acetoxy groups at C-3, C-2, and C-4 positions, respectively, showed the most potent antileishmanial activity (IC 50 = 0.20 µg/mL), comparable to the standard drug, amphotericin B (IC 50 = 0.12 µg/mL). Compound 16 with a β-acetoxy group at C-2 and a double bond between C-14/C-15 showed mild activity (IC 50 = 3.36 µg/mL). Compound 14, which lacks C-14/C-15 double bond, showed comparatively less activity (IC 50 = 3.78 µg/mL). The acetylated derivative of 12 was relatively more active (IC 50 = 6.67 µg/mL) than the derivative 13a (IC 50 = 12.74 mg/mL) with the C-3 β-acetoxy configuration and with no C-16/C-17 double bond. Compound 12 with β-hydroxyl groups at C-2 and C-4 positions was less active (IC 50 = 52.74 µg/mL). These observations indicated that a combination of C-4 β-acetoxy, C-2 α-hydroxyl, and olefinic functionalities at the five-membered ring play an important role in the activity of compounds with a C-3 seneciolyamino group. Compounds with a tigloylamino moiety at C-3 and an α,β-unsaturated carbonyl functionality at ring A and/or at ring D were also studied. Compound 27 showed a higher activity (IC 50 = 1.28 µg/mL) than compounds with an unsaturated five-membered ring and a monomethylamino group at C-20 position (compounds 17, 19, and 26).
Compounds with a 3',4'-dimethyl-2'-pentenamido functionality at C-3 position such as 25 displayed potent activity (IC 50 = 0.46 µg/mL), while compound 15 showed only mild (IC 50 = 6.49 µg/mL) antileishmanial activity. This indicated that the presence of the N,N-formyl(methyl)amino group at C-20 decreases the activity.
In compounds 18 and 28 with a C-3 N-methylamino benzoyl moiety at C-3, compound 18 was found to be less active (IC 50 = 61.44 mg/mL) than compound 28 which lacks an acetoxy group (IC 50 = 26.82 µg/mL).
Compound 20 with a C-14/C-15 double bond and a C-3 amino methyl group was found to be more active (IC 50 = 2.00 µg/mL) than other compounds without such a double bond (e.g., compound 24), whereas the C-3 amino compound 22 was more active than the C-3 N,N-dimethylamino-containing compound 23 (IC 50 = 13.00 µg/mL). The antileishmanial activities of compound 21 and its synthetic derivatives were also studied. The three derivatives were found to be far more active than the parent compound 21.
Steroidal saponins
Saponins 29-31, isolated from Paris polyphylla Smith. (Trilliaceae) (Fig. 3) , showed mild-to-moderate antileishmanial activities. Steroidal saponins are glycosylated derivatives of steroids. Compound 29 exhibited significant activity with IC 50 = 1.59 µg/mL as compared to the standard drug amphotericin B (IC 50 = 0.12 µg/mL). Compounds 30, 31, and 31a did not show any significant antileishmanial activity (Table 3 ) [10] . 
Species of seaweeds
The crude ethanolic extract of various seaweed were also tested for their in vitro antileishmanial activity. These weeds showed mild-to-weak inhibitory activity against the parasites (Table 4 ) [11] [12] .
